Tag: Hatch-Waxman Act
Medications
11
Comments
Multiple Generics: How Competitors Enter After the First Generic Drug Market Entrant
After the first generic drug enters the market, a cascade of competitors follows-each one driving prices lower. Learn how patent exclusivity, authorized generics, PBM contracts, and manufacturing bottlenecks shape the real battle for generic drug dominance.
Medications
9
Comments
What is an ANDA: Abbreviated New Drug Application Explained
An ANDA is the FDA pathway that lets generic drug makers prove their products are identical to brand-name drugs - without repeating costly clinical trials. It's why 90% of U.S. prescriptions are filled with generics that cost 80-85% less.
Medications
14
Comments
First-Mover Advantage: How First Generic Drug Manufacturers Dominate the Market
The first generic drug manufacturer to launch after a patent expires captures up to 80% of the market - and keeps a dominant share for years. Here’s how the Hatch-Waxman Act creates lasting advantage, why big players win, and what’s changing in 2026.
About
Medications
Latest Posts
Exercise for Weight Loss: Cardio vs. Strength Training - What Actually Works
By Orion Kingsworth Dec 2, 2025
Combining Multiple Sedatives: The Hidden Danger of CNS Depression
By Orion Kingsworth Nov 29, 2025
Clinical Outcomes After NTI Generic Switches: What Studies Show
By Orion Kingsworth Feb 14, 2026
